Beijing Beilu Pharmaceutical Co., Ltd. has announced the termination of the concerted action agreement with Zeng Chunhui regarding their joint ownership in Zhejiang Haichang Pharmaceutical Co., Ltd. The agreement was originally signed in December 2019 and renewed in December 2024. Following mutual consultation, both parties will now act independently without a concerted action relationship, which will not affect the company's controlling status in Haichang Pharmaceutical.
Summary generated by AI · Always verify with source document
Beijing Beilu Pharmaceutical Co., Ltd. (hereinafter referred to as "the Company") and all members of the Board of Directors guarantee that the content of this information disclosure is true, accurate, and complete, without false records, misleading statements, or significant omissions.
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.